Synthetic Inhibitors of Ras Palmitoylation: Defining a Novel Class of Drugs Targeting Breast Cancers

doi 10.21236/ada435054
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Targeting K-Ras Cancers

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Kinase Inhibitors: A New Class of Antirheumatic Drugs

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2012English

Selective Tissue Targeting of Synthetic Nucleic Acid Drugs

Journal of Clinical Investigation
Medicine
2019English

Identification of Novel Inhibitors of DLK Palmitoylation and Signaling by High Content Screening

Scientific Reports
Multidisciplinary
2019English

Class I Histone Deacetylase-Selective Novel Synthetic Inhibitors Potently Inhibit Human Tumor Proliferation

Clinical Cancer Research
Cancer ResearchOncology
2004English

Flavonolignans as a Novel Class of Sodium Pump Inhibitors

Frontiers in Physiology
Physiology
2016English

Developing a Novel Class of CLC Chloride-Channel Inhibitors

Biophysical Journal
Biophysics
2017English

Inhibitors of Type II NADH:menaquinone Oxidoreductase Represent a Class of Antitubercular Drugs

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Vaptans: A Novel Class of Drugs Causing Free Water Diuresis

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy